Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels (scientific article)

High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo

Q45855976

Localization of vascular response to VEGF is not dependent on heparin binding

Q46147238

Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier.

Q51455467

Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia.

Q52002244

Cell therapy for heart disease: to genetically modify or not, that is the question.

Q54611628

The athymic nude rat. II. Immunological characteristics

Q72125506

VEGF gene delivery to muscle: potential role for vasculogenesis in adults

Q77652479

Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity

Q80187458

Cultured and freshly isolated adipose tissue-derived cells: fat years for cardiac stem cell therapy

Q82347722

First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction

Q83333593

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Q29547236

Angiogenesis in health and disease

Q29614541

Human adipose tissue is a source of multipotent stem cells

Q29617385

Spontaneously beating cardiomyocytes derived from white mature adipocytes.

Q30492259

Extracellular matrix, inflammation, and the angiogenic response

Q33795730

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

Q34010010

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

Q34086442

Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification

Q35851399

Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials

Q35982220

Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.

Q35987897

Critical role of microenvironmental factors in angiogenesis

Q36089540

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

Q36756406

FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia

Q37295222

Human studies of angiogenic gene therapy

Q37406656

Mechanisms involved in the therapeutic properties of mesenchymal stem cells

Q37635499

New aspects in vascular gene therapy

Q37694065

Myocardial regeneration potential of adipose tissue-derived stem cells

Q37787533

Mesenchymal stem cells for cardiac cell therapy.

Q37808214

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

Q39425647

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

Q40241912

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis

Q40553670

Angiopoietin-1 protects the adult vasculature against plasma leakage.

Q40890338

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

Q41729529

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

Q41757138

Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells

Q44680903

Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression.

Q45384498

P433

issue

P921

main subject

endothelium

Q111140

angiogenesis

Q539568

P304

page(s)

346-356

P577

publication date

2012-10-01

P1433

published in

Human gene therapy methods

Q27723920

P1476

title

Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels

P478

volume

Reverse relations

cites work (P2860)

Q45385684	Bioactive electrospun fibers of poly(glycerol sebacate) and poly(ε-caprolactone) for cardiac patch application
Q38206983	Cardiac Tissue Vascularization: From Angiogenesis to Microfluidic Blood Vessels
Q37512327	Cell and gene therapy approaches for cardiac vascularization
Q39179993	Delivery of growth factor-based therapeutics in vascular diseases: Challenges and strategies
Q26829783	Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine
Q38081027	Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors
Q55395190	Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels.
Q45872982	Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution.
Q92546740	Therapeutic vascularization in regenerative medicine
Q37711465	Treadmill Exercise Training Improves Vascular Endothelial Growth Factor Expression in the Cardiac Muscle of Type I Diabetic Rats
Q38121727	Vascular endothelial growth factor in heart failure